Lucid Diagnostics Inc. Revenue from Contract with Customer, Including Assessed Tax
Lucid Diagnostics Inc. (LUCD) reported Revenue from Contract with Customer, Including Assessed Tax of $1.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-12
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $1.47M, a 26.74% increase year-over-year.
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $1.26M, a 51.69% increase year-over-year.
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $1.16M.
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-03-31 was $828.00K.
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $4.71M, a 8.28% increase from fiscal 2024.
- Lucid Diagnostics Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $4.35M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $1.47M 10-Q · filed 2026-08-12 | $2.73M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.26M 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $4.71M 10-K · filed 2026-03-25 | ||
| 2025-06-30 | $1.16M 10-Q · filed 2026-08-12 | $1.99M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $828.00K 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $4.35M 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |